MUCCIOLI, LORENZO
 Distribuzione geografica
Continente #
AS - Asia 3.832
NA - Nord America 2.545
EU - Europa 2.005
SA - Sud America 200
AF - Africa 196
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.782
Nazione #
US - Stati Uniti d'America 2.482
VN - Vietnam 1.097
SG - Singapore 960
CN - Cina 894
IT - Italia 727
HK - Hong Kong 259
SE - Svezia 259
DE - Germania 223
NL - Olanda 166
KR - Corea 159
GB - Regno Unito 150
BR - Brasile 143
IN - India 132
FR - Francia 114
CI - Costa d'Avorio 90
RU - Federazione Russa 78
IE - Irlanda 74
JP - Giappone 66
FI - Finlandia 51
JO - Giordania 42
BD - Bangladesh 38
CA - Canada 36
ID - Indonesia 31
PH - Filippine 29
BG - Bulgaria 28
AT - Austria 25
ZA - Sudafrica 25
NG - Nigeria 23
TH - Thailandia 23
CH - Svizzera 20
IQ - Iraq 20
MX - Messico 20
AR - Argentina 18
TR - Turchia 18
TG - Togo 15
CO - Colombia 13
SC - Seychelles 13
UA - Ucraina 13
PK - Pakistan 12
TW - Taiwan 12
ES - Italia 11
PL - Polonia 11
EC - Ecuador 10
BE - Belgio 9
GR - Grecia 9
SA - Arabia Saudita 6
UZ - Uzbekistan 6
LT - Lituania 5
RO - Romania 5
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
IL - Israele 4
MA - Marocco 4
AU - Australia 3
CG - Congo 3
CM - Camerun 3
CZ - Repubblica Ceca 3
EE - Estonia 3
HR - Croazia 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
BH - Bahrain 2
DZ - Algeria 2
GH - Ghana 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SO - Somalia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
DJ - Gibuti 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
LU - Lussemburgo 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
OM - Oman 1
RW - Ruanda 1
Totale 8.778
Città #
Singapore 688
Ashburn 377
Hefei 336
Ho Chi Minh City 303
Hanoi 264
Hong Kong 246
San Jose 220
Chandler 158
Seoul 151
Bologna 129
Santa Clara 107
Fairfield 97
Beijing 95
Southend 95
Abidjan 90
Dublin 74
Dallas 70
Los Angeles 70
Milan 69
New York 68
Council Bluffs 60
Tokyo 57
Ann Arbor 55
Houston 55
Princeton 54
Boardman 53
Lauterbourg 51
Seattle 47
Dong Ket 44
Wilmington 44
Woodbridge 44
Amman 42
Cambridge 42
Haiphong 39
Da Nang 36
Modena 34
Munich 32
Rome 32
Turin 32
Florence 31
Bengaluru 30
Redondo Beach 29
Frankfurt am Main 28
Helsinki 28
Sofia 27
Amsterdam 26
Fort Wayne 22
Nuremberg 22
Abeokuta 21
São Paulo 21
Redmond 20
Bern 18
Jakarta 18
Johannesburg 18
Hải Dương 17
Vienna 17
Biên Hòa 16
Buffalo 16
Lappeenranta 16
Shanghai 16
Thái Nguyên 16
Lomé 15
Montreal 15
Chicago 14
Ha Long 14
Quận Bình Thạnh 14
Atlanta 13
Bắc Giang 13
Des Moines 13
Düsseldorf 13
London 13
Naples 12
Phoenix 12
Tongling 12
Berlin 11
Hyderabad 11
Jinan 11
Bắc Ninh 10
Guangzhou 10
Kuban 10
Rimini 10
Washington 10
Điện Bàn 10
Boston 9
Brussels 9
Mexico City 9
Orem 9
Paris 9
The Dalles 9
Bangkok 8
Falls Church 8
Medford 8
Perugia 8
Vũng Tàu 8
Warsaw 8
Yubileyny 8
Can Tho 7
Falkenstein 7
Mülheim 7
Phủ Lý 7
Totale 5.437
Nome #
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data 381
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy 223
Acute-onset focal neurological deficits in rheumatoid arthritis: Consider rheumatoid meningitis 206
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 203
Epilepsy with auditory features: Contribution of known genes in 112 patients 202
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 200
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 196
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study 195
FDG-PET assessment and metabolic patterns in Lafora disease 189
Neurological Manifestations of Long {COVID}: A Single-Center One-Year Experience 187
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 186
Ictal vasodepressive syncope in temporal lobe epilepsy 185
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 182
Juvenile absence epilepsy relapsing as recurrent absence status, mimicking transient global amnesia, in an elderly patient 181
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 180
Epilepsy With Auditory Features: From Etiology to Treatment 175
A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria 173
EEG findings in COVID-19 related encephalopathy 173
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy 170
Treatment with metformin in twelve patients with Lafora disease 170
Epilepsy and inborn errors of metabolism in adults: The diagnostic odyssey of a young woman with medium-chain acyl-coenzyme A dehydrogenase deficiency 163
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 162
Complete Agenesis of Corpus Callosum in KCNQ2-Related Neonatal Epileptic Encephalopathy 160
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 150
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment 149
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 148
The Impact of the COVID-19 Pandemic on People With Epilepsy. An Italian Survey and a Global Perspective 144
Polygenic burden in focal and generalized epilepsies 142
If seizures left speechless: CA-P-S C-A-R-E, a proposal of a new ictal language evaluation protocol 142
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case series 141
Super refractory status epilepticus in Lafora disease interrupted by vagus nerve stimulation: A case report 139
Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients 138
Akinetic mutism in COVID-19-related encephalopathy: A cytokine-mediated maladaptive sickness behavioral response? 137
COVID-19–Associated Encephalopathy and Cytokine-Mediated Neuroinflammation 135
MECP2 duplication syndrome: The electroclinical features of a case with long-term evolution 134
SCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus 132
Anti-LGI1 encephalitis following COVID-19 vaccination: a case series 130
Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease 126
Pseudohyperkalemia due to cryohydrocytosis in GLUT1 deficiency syndrome. A case report and literature review 124
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy 116
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 115
Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction 110
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis 109
VAL-1221 for the treatment of patients with Lafora disease: Study protocol for a single-arm, open-label clinical trial 100
Low CSF hypocretin-1 levels in an adult patient with hypothalamic hamartoma 98
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals 98
Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy 98
Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review 93
Carotid free-floating thrombus in COVID-19: a cerebrovascular disorder of cytokine storm-related immunothrombosis 92
Genome-wide meta-analysis of over 29,000 people with epilepsy reveals 26 loci and subtype-specific genetic architecture 91
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 89
Subcortical Myoclonus in Coronavirus Disease 2019: Comprehensive Evaluation of a Patient 88
Real-world experience with cannabidiol as add-on treatment in drug-resistant epilepsy 86
Subacute-onset paraneoplastic autonomic neuropathy associated with prostate cancer 84
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 81
Anti-Ma2-associated limbic encephalitis presenting with transient epileptic amnesia 75
Hemorrhagic cerebral vasculopathy in Susac syndrome 72
Neurological Manifestations of Long COVID: A Single-Center One-Year Experience [Response to Letter] 66
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease 60
Syndrome of inappropriate antidiuresis as a maladaptive stress response shared by coronavirus disease 2019 and other cytokine storm disorders 57
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy 51
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 51
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 49
Sleep and Awake EEG Findings in a Patient with Lafora Disease: From Presymptomatic to Overt Disease Stage 48
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets 45
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants 40
Impact of neurotoxicity and steroid therapy on cancer progression-free survival in lymphoma patients treated with anti-CD19 CAR T cells 38
Letter to the Editor: “Record-Linkage in Population Studies on Epilepsy: Pros and Cons” 37
Risk of SUDEP during infancy 31
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 28
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment 24
Standard complete blood count to predict long-term outcomes in febrile infection–related epilepsy syndrome (FIRES): A multicenter study 18
null 1
Totale 8.992
Categoria #
all - tutte 24.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 0 0 0 0 0 12 61
2021/2022648 28 7 30 73 51 26 11 61 36 107 132 86
2022/2023889 81 84 34 67 94 76 32 53 165 38 121 44
2023/2024439 16 42 36 56 38 81 16 57 12 42 24 19
2024/20251.631 69 197 113 99 153 72 72 53 31 198 164 410
2025/20264.810 701 550 399 458 380 179 506 199 878 392 168 0
Totale 8.992